ArticleNeuro-oncology2024

The ERK inhibitor LY3214996 augments anti-PD-1 immunotherapy in preclinical mouse models of BRAFV600E melanoma brain metastasis.

Magali A de Sauvage et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.